Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Invivo Therapeutics Holdings Corp. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
NVIV is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 4
- −10 vs. Q4 2023
- Shares held
- 23.7K
- −69.6K (−74.6%) vs. Q4 2023
- Total value
- $5.22K
- −$62.9K (−92.3%) vs. Q4 2023
- New holders
- 2
- 0 more added
- Sold out
- 12
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 4 | $5.22K |
| Q4 2023 | 14 | $68.1K |
| Q3 2023 | 15 | $118.5K |
| Q2 2023 | 15 | $131.0K |
| Q1 2023 | 20 | $123.7K |
| Q4 2022 | 17 | $718.7K |
| Q3 2022 | 16 | $703.0K |
| Q2 2022 | 13 | $257.0K |
| Q1 2022 | 1 | $1.00K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Invivo Therapeutics Holdings Corp.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 23,741 | $5.22K | 0.00% | +23,741 | New |
| Vima LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Sugarloaf Wealth Management, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2 | $0 | 0.00% | +2 | New |
| BlackRock Inc. | 0 | $0 | 0.00% | −34,714−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −31,238−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −18,677−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8,395−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Indiana Trust & Investment Management CO | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Colonial Trust Advisors | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Provenance Wealth Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |